The FDA expanded the drug’s indication from 8 years and older to one year and older for delaying progression of type 1 diabetes.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/tzield-approved-younger-children-early-stage-t1d-2026a1000ct8?src=rss
Author :
Publish date : 2026-04-22 23:03:00
Copyright for syndicated content belongs to the linked Source.